{"schema_version":"secwatch.filing_event.v1","accession":"0000784199-24-000013","form_type":"8-K","ticker":"AORT","cik":"0000784199","company_name":"ARTIVION, INC.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.912095+00:00","generated_at":"2026-06-06T01:41:30.629942+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Artivion Q4 revenue $93.7M (+18% YoY); guides 2024 rev $382-396M","bullets":["Q4 revenue $93.7M (+18% GAAP, +15% constant currency); full year $354.0M (+13%).","Q4 non-GAAP net income $4.6M ($0.11 EPS); adjusted EBITDA $15.3M (+40% YoY).","Full year net loss ($30.7M); non-GAAP net income $8.4M ($0.20 EPS); free cash flow $11.4M.","2024 guidance: revenue $382-396M (+8-12%), adjusted EBITDA $68-72M (+26-34%).","AMDS PERSEVERE trial met endpoints: 72% mortality reduction, 52% fewer MAEs; FDA PMA expected H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000784199-24-000013","json":"https://secwatch.observer/filing/0000784199-24-000013.json","markdown":"https://secwatch.observer/filing/0000784199-24-000013.md","text":"https://secwatch.observer/filing/0000784199-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000013/0000784199-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000013/aort-20240215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:41:30.629942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ccaba4ba22f105f3936e5050b1c85d42243351e7","claim":"ARTIVION, INC. reported fourth quarter ended December 31, 2023 results: revenue $93.7 million, net income ($4.0) million, or ($0.10) per fully diluted common share, EPS ($0.10) per fully diluted common share.","evidence_excerpt":"Phone: 770-419-3355 Artivion Reports Fourth Quarter and Full Year 2023 Financial Results Fourth Quarter and Recent Business Highlights: • Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis • Achieved","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000013/0000784199-24-000013-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$93.7 million"},{"label":"Net income","value":"($4.0) million, or ($0.10) per fully diluted common share"},{"label":"EPS","value":"($0.10) per fully diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d04bc022c97b78aa93d6bf4f9625bd669a727f0f","claim":"ARTIVION, INC. reported full year 2024 results: revenue $382 to $396 million. Guidance initiated.","evidence_excerpt":"The Company expects revenues for the full year 2024 to be in the range of $382 to $396 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000013/0000784199-24-000013-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"Revenue","value":"$382 to $396 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"d1034a256e0129a64db5d3c90c59aa864b4c1f84","claim":"ARTIVION, INC. reported full year ended December 31, 2023 results: revenue $354.0 million, net income ($30.7) million, or ($0.75) per fully diluted common share, EPS ($0.75) per fully diluted common share.","evidence_excerpt":"fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis • Achieved revenue of $354.0 million for the full year of 2023 versus $313.8 million for the full year of 2022, an increase of 13% on a GAAP basis and 12% on a non-GAAP constant currency basis • Net loss was ($4.0)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000013/0000784199-24-000013-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2023"},{"label":"Revenue","value":"$354.0 million"},{"label":"Net income","value":"($30.7) million, or ($0.75) per fully diluted common share"},{"label":"EPS","value":"($0.75) per fully diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}